论文部分内容阅读
Background & aims: Intestinal failure associated liver disease (IFALD) complicates the treatment of patients with short bowel syndrome (SBS).Some studies have shown omega-3 polyunsaturated fatty acids (ω-3 PUFAs) have favorable effects in treating IFALD in children.We, therefore, investigate the effects of ω-3 PUFAs supplemented intravenous lipid emulsion (ILE) on IFALD in adults.